Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Nerac IPDex™
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us

Pharmaceutical

Sample Research Report: Drug Product Literature Search and Review

By Richard Hendriks, Ph.D., Nerac Analyst
Originally published April 30, 2021
This sample report demonstrates Nerac’s approach to providing drug product literature search support. Read more here.

Regenerative Medicine: A New Kind of Cellular Service

By Tyler Stahl, M.S., Nerac Analyst
Originally published April 27, 2017
This article explores recent trends in the developing field of tissue engineering and regenerative medicine.
Read More

Exciting Novel, but High-Cost Developments in Cancer Treatment: Immunotherapy continues to advance as a validated approach

By Holly Magna, Ph.D., Nerac Analyst
Originally published November 28, 2016
A review of some of the newly marketed therapies and some still in development, as well as their complications, risks and advantages
Read More

Drug Safety Updates – Regulations and FDA Guidance for Industry

By Stephen Buxser, Ph.D., Nerac Analyst
Originally published November 28, 2016
For drugs licensed for sale in the United States, as well as elsewhere in the world, there are requirements for periodic literature updates/reviews. This article describes the legal requirements for drug safety and efficacy reporting.
Read More

Antibiotic Resistant Bacteria – Threats and Opportunities.

By Stephen E. Buxser, Ph.D., Nerac Analyst,
Originally Published: November 6, 2015
This report looks into the issue of antibiotic resistance and the development of new antimocrobials. Read More

The Fight Over Who Invented siRNA

By John Leavitt, Ph.D., Nerac Analyst
Originally Published: June 1st, 2015
The Tuschl II priority application describing the invention of siRNA for therapeutic gene silencing assigned to Max-Planck Institute was filed in the European Patent Office to establish a priority date of the December 1, 2000.
Read More

Epithelial to Mesenchymal Transition in Lethal Forms of Cancer and Fibrotic Disease

By John Leavitt, Ph.D., Nerac Analyst,
Originally Published: February 17th, 2015
This article describes very recent developments cancer genetics and cell biology that helps to understand the importance of EMT in cancer and fibrosis mortality. Read More

Ebola: Do we need to worry?

By Rebecca Ryznar, Ph.D., Nerac Associate Analyst
Originally published Sept. 2, 2014
Zaire Ebola virus (EBOV), the particular Ebola viral strain currently spreading across West Africa, causes the most virulent hemorrhagic fever known to man, and kills up to 90% of those infected. Read more

A Glimpse into the Vital Core of Tumor Cell Development

By John Leavitt, Ph.D. Nerac Analyst
Originally Published: August 12, 2014
In 1987, my colleagues at Stanford and I published a paper that clearly demonstrated that expression of a charge-altered mutant human beta-actin (glycine to aspartic acid substitution at amino acid 245; G245D) caused non-tumorigenic, immortalized human fibroblasts to form aggressive tumors in nude mice (Leavitt et al, 1987a). Read more

Nutraceutical IP and Regulatory Claims

Originally published September, 2008
Food makers increasingly rely on patented technologies to improve functionality, but strict regulations hamper marketing benefits.
Read more

  • 1
  • 2
  • Next Page »
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room
  • Facebook
  • Google+
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2023 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000